NCT02961829View on ClinicalTrials.gov

Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2020

Conditions
Chronic InfectionHIV
Interventions
DRUG

Maraviroc

antiretroviral intensification

DRUG

Dolutegravir

antiretroviral intensification

BIOLOGICAL

Dendritic Cell Vaccine

Therapeutic vaccination

DRUG

Auranofin

purging

DRUG

Sirtuin Histone deacetylase inhibitor

latency disruption

Trial Locations (1)

04040002

CCDI, São Paulo

Sponsors

Collaborators (1)

ViiV Healthcare
All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

collaborator

ViiV Healthcare

INDUSTRY

lead

Federal University of São Paulo

OTHER

NCT02961829 - Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure | Biotech Hunter | Biotech Hunter